Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: Int J Cancer. 2018 Feb 10;142(12):2485–2490. doi: 10.1002/ijc.31277

Figure 2.

Figure 2

Disease outcomes in patients with HPV+ oropharynx cancer according to exposure type. There was no statistically significant difference in terms of (A) locoregional control, (p=0.89) or (B) disease-free survival (p=0.21) in patients with occupational versus non-occupational exposure.